Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15351027rdf:typepubmed:Citationlld:pubmed
pubmed-article:15351027lifeskim:mentionsumls-concept:C2926606lld:lifeskim
pubmed-article:15351027lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:15351027lifeskim:mentionsumls-concept:C2607943lld:lifeskim
pubmed-article:15351027lifeskim:mentionsumls-concept:C0268594lld:lifeskim
pubmed-article:15351027lifeskim:mentionsumls-concept:C0024487lld:lifeskim
pubmed-article:15351027lifeskim:mentionsumls-concept:C0260061lld:lifeskim
pubmed-article:15351027pubmed:issue3lld:pubmed
pubmed-article:15351027pubmed:dateCreated2004-9-7lld:pubmed
pubmed-article:15351027pubmed:abstractTextGlutaric aciduria type 1 is an inborn error of lysine, hydroxylysine, and tryptophan metabolism caused by deficiency of glutaryl-coenzyme A dehydrogenase. The disease often appears in infancy with an encephalopathic episode that results in acute basal ganglia and white matter degeneration. The neuroimaging findings in glutaric aciduria type 1 have been well defined. However, the changes in magnetic resonance spectroscopy, a noninvasive tool for identifying the biochemical state of the brain, are scarce in glutaric aciduria type 1. This report presents the magnetic resonance spectroscopy findings in a 19-month-old male with glutaric aciduria type 1. Magnetic resonance spectroscopy of right frontal white matter and right lentiform nuclei revealed decreased N-acetylaspartate/creatine ratio, slightly increased choline/creatine ratio, and increased myoinositol/creatine ratio, compared with the age-matched control patients. We thought that these changes were in accordance with neuroaxonal damage, demyelination, and astrocytosis in these areas. In conclusion, proton magnetic resonance spectroscopy provides a tool for assessing metabolic disturbances and the extent of brain damage noninvasively in glutaric aciduria type 1.lld:pubmed
pubmed-article:15351027pubmed:languageenglld:pubmed
pubmed-article:15351027pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15351027pubmed:citationSubsetIMlld:pubmed
pubmed-article:15351027pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15351027pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15351027pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15351027pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15351027pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15351027pubmed:statusMEDLINElld:pubmed
pubmed-article:15351027pubmed:monthSeplld:pubmed
pubmed-article:15351027pubmed:issn0887-8994lld:pubmed
pubmed-article:15351027pubmed:authorpubmed-author:KurulSemraSlld:pubmed
pubmed-article:15351027pubmed:authorpubmed-author:DirikErayElld:pubmed
pubmed-article:15351027pubmed:authorpubmed-author:CakmakçiHanda...lld:pubmed
pubmed-article:15351027pubmed:issnTypePrintlld:pubmed
pubmed-article:15351027pubmed:volume31lld:pubmed
pubmed-article:15351027pubmed:ownerNLMlld:pubmed
pubmed-article:15351027pubmed:authorsCompleteYlld:pubmed
pubmed-article:15351027pubmed:pagination228-31lld:pubmed
pubmed-article:15351027pubmed:dateRevised2006-5-23lld:pubmed
pubmed-article:15351027pubmed:meshHeadingpubmed-meshheading:15351027...lld:pubmed
pubmed-article:15351027pubmed:meshHeadingpubmed-meshheading:15351027...lld:pubmed
pubmed-article:15351027pubmed:meshHeadingpubmed-meshheading:15351027...lld:pubmed
pubmed-article:15351027pubmed:meshHeadingpubmed-meshheading:15351027...lld:pubmed
pubmed-article:15351027pubmed:meshHeadingpubmed-meshheading:15351027...lld:pubmed
pubmed-article:15351027pubmed:meshHeadingpubmed-meshheading:15351027...lld:pubmed
pubmed-article:15351027pubmed:meshHeadingpubmed-meshheading:15351027...lld:pubmed
pubmed-article:15351027pubmed:meshHeadingpubmed-meshheading:15351027...lld:pubmed
pubmed-article:15351027pubmed:meshHeadingpubmed-meshheading:15351027...lld:pubmed
pubmed-article:15351027pubmed:year2004lld:pubmed
pubmed-article:15351027pubmed:articleTitleGlutaric aciduria type 1: proton magnetic resonance spectroscopy findings.lld:pubmed
pubmed-article:15351027pubmed:affiliationDepartment of Pediatric Neurology, Dokuz Eylül University Faculty of Medicine, Izmir, Turkey.lld:pubmed
pubmed-article:15351027pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15351027pubmed:publicationTypeCase Reportslld:pubmed